148 related articles for article (PubMed ID: 11747428)
1. Designed peptide analogues of the potassium channel blocker ShK toxin.
Lanigan MD; Pennington MW; Lefievre Y; Rauer H; Norton RS
Biochemistry; 2001 Dec; 40(51):15528-37. PubMed ID: 11747428
[TBL] [Abstract][Full Text] [Related]
2. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.
Pennington MW; Lanigan MD; Kalman K; Mahnir VM; Rauer H; McVaugh CT; Behm D; Donaldson D; Chandy KG; Kem WR; Norton RS
Biochemistry; 1999 Nov; 38(44):14549-58. PubMed ID: 10545177
[TBL] [Abstract][Full Text] [Related]
3. A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity.
Cotton J; Crest M; Bouet F; Alessandri N; Gola M; Forest E; Karlsson E; Castañeda O; Harvey AL; Vita C; Ménez A
Eur J Biochem; 1997 Feb; 244(1):192-202. PubMed ID: 9063464
[TBL] [Abstract][Full Text] [Related]
4. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.
Rauer H; Pennington M; Cahalan M; Chandy KG
J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508
[TBL] [Abstract][Full Text] [Related]
5. Ionisation behaviour and solution properties of the potassium-channel blocker ShK toxin.
Tudor JE; Pennington MW; Norton RS
Eur J Biochem; 1998 Jan; 251(1-2):133-41. PubMed ID: 9492277
[TBL] [Abstract][Full Text] [Related]
6. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3.
Lanigan MD; Kalman K; Lefievre Y; Pennington MW; Chandy KG; Norton RS
Biochemistry; 2002 Oct; 41(40):11963-71. PubMed ID: 12356296
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone.
Pennington MW; Byrnes ME; Zaydenberg I; Khaytin I; de Chastonay J; Krafte DS; Hill R; Mahnir VM; Volberg WA; Gorczyca W
Int J Pept Protein Res; 1995 Nov; 46(5):354-8. PubMed ID: 8567178
[TBL] [Abstract][Full Text] [Related]
8. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
Beeton C; Smith BJ; Sabo JK; Crossley G; Nugent D; Khaytin I; Chi V; Chandy KG; Pennington MW; Norton RS
J Biol Chem; 2008 Jan; 283(2):988-97. PubMed ID: 17984097
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases.
Norton RS; Pennington MW; Wulff H
Curr Med Chem; 2004 Dec; 11(23):3041-52. PubMed ID: 15578998
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of the sea anemone toxin ShK recognizing the Kv1.3 channel explored by docking and molecular dynamic simulations.
Jin L; Wu Y
J Chem Inf Model; 2007; 47(5):1967-72. PubMed ID: 17718553
[TBL] [Abstract][Full Text] [Related]
11. An essential binding surface for ShK toxin interaction with rat brain potassium channels.
Pennington MW; Mahnir VM; Khaytin I; Zaydenberg I; Byrnes ME; Kem WR
Biochemistry; 1996 Dec; 35(51):16407-11. PubMed ID: 8987971
[TBL] [Abstract][Full Text] [Related]
12. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide.
Kalman K; Pennington MW; Lanigan MD; Nguyen A; Rauer H; Mahnir V; Paschetto K; Kem WR; Grissmer S; Gutman GA; Christian EP; Cahalan MD; Norton RS; Chandy KG
J Biol Chem; 1998 Dec; 273(49):32697-707. PubMed ID: 9830012
[TBL] [Abstract][Full Text] [Related]
13. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain.
Pennington MW; Mahnir VM; Krafte DS; Zaydenberg I; Byrnes ME; Khaytin I; Crowley K; Kem WR
Biochem Biophys Res Commun; 1996 Feb; 219(3):696-701. PubMed ID: 8645244
[TBL] [Abstract][Full Text] [Related]
14. A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.
Harvey AJ; Gable RW; Baell JB
Bioorg Med Chem Lett; 2005 Jul; 15(13):3193-6. PubMed ID: 15935664
[TBL] [Abstract][Full Text] [Related]
15. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.
Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016
[TBL] [Abstract][Full Text] [Related]
16. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus.
Castañeda O; Sotolongo V; Amor AM; Stöcklin R; Anderson AJ; Harvey AL; Engström A; Wernstedt C; Karlsson E
Toxicon; 1995 May; 33(5):603-13. PubMed ID: 7660365
[TBL] [Abstract][Full Text] [Related]
18. A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties.
Peigneur S; Billen B; Derua R; Waelkens E; Debaveye S; Béress L; Tytgat J
Biochem Pharmacol; 2011 Jul; 82(1):81-90. PubMed ID: 21477583
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone.
Tudor JE; Pallaghy PK; Pennington MW; Norton RS
Nat Struct Biol; 1996 Apr; 3(4):317-20. PubMed ID: 8599755
[No Abstract] [Full Text] [Related]
20. Maurotoxin and the Kv1.1 channel: voltage-dependent binding upon enantiomerization of the scorpion toxin disulfide bridge Cys31-Cys34.
Lecomte C; Ben Khalifa R; Martin-Eauclaire MF; Kharrat R; El Ayeb M; Darbon H; Rochat H; Crest M; Sabatier JM
J Pept Res; 2000 Mar; 55(3):246-54. PubMed ID: 10727107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
